Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma - Duvic, M; Olsen, E A; Breneman, D; Pacheco, T R; Parker, S; Vonderheid, E C; Abuav, R; Ricker, J L; Rizvi, S; Chen, C; Boileau, K; Gunchenko, A; Sanz-Rodriguez, C; Geskin, L J (Clin Lymphoma Myeloma, 2009)